0.93 USD
↘ 0.02 (1.71%)LIVE (AS OF 02:00 PM EST)
Perspective Therapeutics, Inc. (CATX) trades at $0.93 per share. Both sides of the analysis point lower: technicals flash "Sell" and fundamentals confirm with a "Sell" reading. This is driven by a concerning Altman Z-Score in the distress zone, a weak Piotroski F-Score of 1/9, negative Return on Equity, a bearish Death Cross on the long-term moving averages and bearish long-term moving average alignment. On valuation, CATX trades roughly in line with sector averages — neither particularly cheap nor expensive.
Technical & fundamental data as of Nov 13, 2026.